BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3966929)

  • 1. The development of tolerance to antilipolytic agents by isolated rat adipocytes.
    Stratton GD; Myles DD; Strong P; Skidmore IF
    Biochem Pharmacol; 1985 Jan; 34(2):275-9. PubMed ID: 3966929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of tolerance to antilipolytic agents in rats.
    Myles DD; Stratton GD; Strong P; Skidmore IF
    Biochem Pharmacol; 1985 Jan; 34(2):269-74. PubMed ID: 3966928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors.
    Strong P; Coleman RA; Humphrey PP
    Prostaglandins; 1992 Jun; 43(6):559-66. PubMed ID: 1410520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilipolytic activity of viprostol, a transdermally active antihypertensive PGE2 analog.
    Crandall DL; Vu V; Lizzo FH; Davis BA; Cervoni P
    Prostaglandins; 1987 May; 33(5):767-73. PubMed ID: 2438724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antilipolytic effect of prostaglandin E2 in perifused rat adipocytes.
    Richelsen B; Pedersen SB
    Endocrinology; 1987 Oct; 121(4):1221-6. PubMed ID: 3308432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of prostaglandin E2 receptor binding is accompanied by reduced antilipolytic effects of prostaglandin E2 in isolated rat adipocytes.
    Richelsen B; Beck-Nielsen H
    J Lipid Res; 1985 Jan; 26(1):127-34. PubMed ID: 2857758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid.
    Johansson SM; Yang JN; Lindgren E; Fredholm BB
    Acta Physiol (Oxf); 2007 May; 190(1):87-96. PubMed ID: 17428236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of adenylate cyclase and stimulation of a high affinity GTPase by the antilipolytic agents, nicotinic acid, acipimox and various related compounds.
    Aktories K; Schultz G; Jakobs KH
    Arzneimittelforschung; 1983; 33(11):1525-7. PubMed ID: 6140925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds.
    Kather H; Aktories K; Schulz G; Jakobs KH
    FEBS Lett; 1983 Sep; 161(1):149-52. PubMed ID: 6350045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue.
    Chatzipanteli K; Rudolph S; Axelrod L
    Diabetes; 1992 Aug; 41(8):927-35. PubMed ID: 1628767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hormone-stimulated human fat cell-lipolysis by prostaglandin E2 and its synthetic analogue sulprostrone.
    Kather H
    Prostaglandins Leukot Med; 1982 May; 8(5):525-9. PubMed ID: 6954554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age related changes in the antilipolytic effects of nicotinic acid in rat adipose tissue.
    Caparrotta L; Fassina G; Gaion RM; Tessari F
    Br J Pharmacol; 1983 Dec; 80(4):663-70. PubMed ID: 6571225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of indomethacin with the antilipolytic effect of prostaglandin E2 in rat adipocytes.
    Richelsen B
    Mol Cell Endocrinol; 1988 Jul; 58(1):85-91. PubMed ID: 3208990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipolysis by agents acting via adenylate cyclase in fat cells from infants and adults.
    Marcus C; Sonnenfeld T; Karpe B; Bolme P; Arner P
    Pediatr Res; 1989 Sep; 26(3):255-9. PubMed ID: 2555764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilipolytic activity of tiadenol-nicotinate in isolated fat cells: a comparison with its parent drugs.
    Gaion RM; Murari L; Cima L; Valenti P; Da Re P
    Drugs Exp Clin Res; 1985; 11(6):407-11. PubMed ID: 3836137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged treatment of adipocytes with PGE1, N6-phenylisopropyl adenosine and nicotinic acid on G-proteins and antilipolytic sensitivity.
    Green A; Milligan G; Belt SE
    Biochem Soc Trans; 1991 Apr; 19(2):212S. PubMed ID: 1909659
    [No Abstract]   [Full Text] [Related]  

  • 18. Coupling of adenylate cyclase to lipolysis in permeabilized adipocytes: direct evidence that an antilipolytic effect of insulin is independent of adenylate cyclase.
    Mooney RA; Swicegood CL; Marx RB
    Endocrinology; 1986 Nov; 119(5):2240-8. PubMed ID: 3095104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 action and binding in human adipocytes: effects of sex, age, and obesity.
    Richelsen B
    Metabolism; 1988 Mar; 37(3):268-75. PubMed ID: 3422703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of forskolin and the antilipolytic agents insulin and nicotinic acid on cyclic AMP levels in rat epididymal adipocytes.
    Fatemi SH
    Biomed Biochim Acta; 1986; 45(4):539-47. PubMed ID: 2423074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.